|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/01/20 Adicet Bio, Inc. 8-K/A:4,9 9/25/20 11:159K Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 8-K/A Amendment to Current Report HTML 30K 2: EX-16.1 Letter re: a Change in Accountant HTML 6K 7: R1 Document and Entity Information HTML 51K 9: XML IDEA XML File -- Filing Summary XML 12K 6: XML XBRL Instance -- d38272d8ka_htm XML 14K 8: EXCEL IDEA Workbook of Financial Reports XLSX 6K 4: EX-101.LAB XBRL Labels -- acet-20200925_lab XML 59K 5: EX-101.PRE XBRL Presentations -- acet-20200925_pre XML 37K 3: EX-101.SCH XBRL Schema -- acet-20200925 XSD 12K 10: JSON XBRL Instance as JSON Data -- MetaLinks 13± 20K 11: ZIP XBRL Zipped Folder -- 0001193125-20-261344-xbrl Zip 11K
| EX-16.1 |
Exhibit 16.1
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Adicet Bio, Inc. (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of Adicet Bio, Inc. dated September 25, 2020. We agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ PricewaterhouseCoopers LLP
San Jose, California
Attachment
| This ‘8-K/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/1/20 | |||
| For Period end: | 9/25/20 | 8-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/11/21 Adicet Bio, Inc. 424B5 1:1M ActiveDisclosure/FA 2/10/21 Adicet Bio, Inc. 424B5 1:919K ActiveDisclosure/FA 12/01/20 Adicet Bio, Inc. 424B5 1:780K Donnelley … Solutions/FA 10/02/20 Adicet Bio, Inc. S-8 10/02/20 4:114K Donnelley … Solutions/FA |